Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Kudret Erkenekli, Cantekin Iskender, Efser Oztas, Ayse Seval Özgü-Erdinç, Aykan Yucel & Dilek Uygur. (2015) Clinical, but Not Laboratory Features Are Predictive of Risk of Subsequent Development of Preeclampsia in Patients With Isolated Proteinuria After Midgestation. Hypertension in Pregnancy 34:4, pages 495-505.
Read now
Read now
Tinnakorn Chaiworapongsa, Roberto Romero, Steven J. Korzeniewski, Josef M. Cortez, Athina Pappas, Adi L. Tarca, Piya Chaemsaithong, Zhong Dong, Lami Yeo & Sonia S. Hassan. (2014) Plasma concentrations of angiogenic/anti-angiogenic factors have prognostic value in women presenting with suspected preeclampsia to the obstetrical triage area: a prospective study. The Journal of Maternal-Fetal & Neonatal Medicine 27:2, pages 132-144.
Read now
Read now
Theresa Engels, Juliane Pape, Katharina Schoofs, Wolfgang Henrich & Stefan Verlohren. (2013) Automated measurement of sFlt1, PlGF and sFlt1/PlGF ratio in differential diagnosis of hypertensive pregnancy disorders. Hypertension in Pregnancy 32:4, pages 459-473.
Read now
Read now
Jimmy Espinoza. (2012) The need to redefine preeclampsia. Expert Opinion on Medical Diagnostics 6:4, pages 347-357.
Read now
Read now
Katerina Papakonstantinou, Emanouel Economou, Elena Koupa, Ilias Babameto, Dimitris Hasiakos & Nikolaos Vitoratos. (2011) Antepartum and postpartum maternal plasma levels of E-selectin and VE-cadherin in preeclampsia, gestational proteinuria and gestational hypertension. The Journal of Maternal-Fetal & Neonatal Medicine 24:8, pages 1027-1032.
Read now
Read now
Articles from other publishers (19)
Nataliia Sergeevna Karpova, Olga Pavlovna Dmitrenko & Tatyana Sergeevna Budykina. (2023) Literature Review: The sFlt1/PlGF Ratio and Pregestational Maternal Comorbidities: New Risk Factors to Predict Pre-Eclampsia. International Journal of Molecular Sciences 24:7, pages 6744.
Crossref
Crossref
Chikako Hirashima, Manabu Ogoyama, Miyuki Abe, Satoru Shiraishi, Taro Sugase, Toshiro Niki, Shigeki Matsubara & Akihide Ohkuchi. (2018) Clinical usefulness of serum levels of soluble fms-like tyrosine kinase 1/placental growth factor ratio to rule out preeclampsia in women with new-onset lupus nephritis during pregnancy. CEN Case Reports 8:2, pages 95-100.
Crossref
Crossref
Geoff K Frampton, Jeremy Jones, Micah Rose & Liz Payne. (2016) Placental growth factor (alone or in combination with soluble fms-like tyrosine kinase 1) as an aid to the assessment of women with suspected pre-eclampsia: systematic review and economic analysis. Health Technology Assessment 20:87, pages 1-160.
Crossref
Crossref
Indira Álvarez-Fernández, Belén Prieto & Francisco V. Álvarez. (2016) Preeclampsia. Revista del Laboratorio Clínico 9:2, pages 81-89.
Crossref
Crossref
Marwa Ben Ali Gannoun, Séverine Bourrelly, Nozha Raguema, Hedia Zitouni, Eva Nouvellon, Wided Maleh, Afraa Brahim Chemili, Raja Elfeleh, Wassim Almawi, Touhami Mahjoub & Jean-Christophe Gris. (2016) Placental growth factor and vascular endothelial growth factor serum levels in Tunisian Arab women with suspected preeclampsia. Cytokine 79, pages 1-6.
Crossref
Crossref
Ziyan Jiang, Yanfen Zou, Zhiping Ge, Qing Zuo, Shi Yun Huang & Lizhou Sun. (2015) A Role of sFlt-1 in Oxidative Stress and Apoptosis in Human and Mouse Pre-Eclamptic Trophoblasts1. Biology of Reproduction 93:3.
Crossref
Crossref
Juha Rasanen, Matthew J. Quinn, Amber Laurie, Eric Bean, Charles T. RobertsJr.Jr., Srinivasa R. Nagalla & Michael G. Gravett. (2015) Maternal serum glycosylated fibronectin as a point-of-care biomarker for assessment of preeclampsia. American Journal of Obstetrics and Gynecology 212:1, pages 82.e1-82.e9.
Crossref
Crossref
Takako Ohmaru, Akihide Ohkuchi, Shigeaki Muto, Chikako Hirashima, Shigeki Matsubara & Mitsuaki Suzuki. (2013) Increased antiangiogenetic factors in severe proteinuria without hypertension in pregnancy: is kidney biopsy necessary?. CEN Case Reports 3:1, pages 86-89.
Crossref
Crossref
K.-Y. Jen & Z.G. Laszik. 2014. Pathobiology of Human Disease. Pathobiology of Human Disease
2767
2787
.
Jeanne Sibiude, Jean Guibourdenche, Marie-Danielle Dionne, Camille Le Ray, Olivia Anselem, Raphaël Serreau, François Goffinet & Vassilis Tsatsaris. (2012) Placental Growth Factor for the Prediction of Adverse Outcomes in Patients with Suspected Preeclampsia or Intrauterine Growth Restriction. PLoS ONE 7:11, pages e50208.
Crossref
Crossref
Zhen Liu, Gijs B. Afink & Peter ten Dijke. (2012) Soluble fms-like tyrosine kinase 1 and soluble endoglin are elevated circulating anti-angiogenic factors in pre-eclampsia. Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health 2:4, pages 358-367.
Crossref
Crossref
Neil CAMPBELL, Robert OGLE, Charlene THORNTON, Annemarie HENNESSY & Jason ABBOTT. (2011) Urinary placental growth factor differentiates the hypertensive disorders of pregnancy. Australian and New Zealand Journal of Obstetrics and Gynaecology 51:6, pages 523-526.
Crossref
Crossref
M. V. Korokin, M. V. Pokrovsky, O. O. Novikov, V. V. Gureev, T. A. Denisyuk, L. V. Korokina, O. S. Polyanskaya, V. A. Ragulina, T. G. Pokrovskaya, L. M. Danilenko & A. S. Belous. (2011) Effect of L-Arginine, Vitamin B6 and Folic Acid on Parameters of Endothelial Dysfunction and Microcirculation in the Placenta in Modelinhg of L-NAME-Induced NO Deficiency. Bulletin of Experimental Biology and Medicine 152:1, pages 70-72.
Crossref
Crossref
Attila Molvarec, András Szarka, Szilvia Walentin, Endre Szűcs, Bálint Nagy & János Rigó. (2010) Circulating angiogenic factors determined by electrochemiluminescence immunoassay in relation to the clinical features and laboratory parameters in women with pre-eclampsia. Hypertension Research 33:9, pages 892-898.
Crossref
Crossref
Joanna L James, Guy S Whitley & Judith E Cartwright. (2010) Pre‐eclampsia: fitting together the placental, immune and cardiovascular pieces. The Journal of Pathology 221:4, pages 363-378.
Crossref
Crossref
Jimmy Espinoza, John E. Uckele, Robert A. Starr, David E. Seubert, Andres F. Espinoza & Stanley M. Berry. (2010) Angiogenic imbalances: the obstetric perspective. American Journal of Obstetrics and Gynecology 203:1, pages 17.e1-17.e8.
Crossref
Crossref
ANGUS RITCHIE & MARK A BROWN. (2010) PROTEINURIA IN PREECLAMPSIA: FROM BENCH TO BEDSIDE. Fetal and Maternal Medicine Review 21:1, pages 1-23.
Crossref
Crossref
. (2009) Current World Literature. Current Opinion in Obstetrics & Gynecology 21:6, pages 541-549.
Crossref
Crossref
Mamoru Morikawa, Takashi Yamada & Hisanori Minakami. (2009) Outcome of pregnancy in patients with isolated proteinuria. Current Opinion in Obstetrics & Gynecology 21:6, pages 491-495.
Crossref
Crossref